DaVita Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DaVita Inc. (DVA) shares fell 1.21% to $234.10 on Monday, underperforming the broader market and snapping a two-day winning streak. The decline occurred amid a poor trading session where the S&P 500 and Dow Jones also dropped. DaVita closed 2.31% below its 52-week high of $239.64. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DaVita Inc. (DVA) shed 1.21% to $234.10 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
The stock's fall snapped a two-day winning streak.
DaVita Inc. closed 2.31% short of its 52-week high of $239.64, which the company achieved on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as UnitedHealth Group Inc. (UNH) fell 1.07% to $421.55, Icon PLC (ICLR) fell 2.25% to $166.18, and Quest Diagnostics Inc. (DGX) fell 1.43% to $207.66.
Trading volume (504,795) remained 394,821 below its 50-day average volume of 899,616.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1712ET